Fundz

Who to call at Enveric Biosciences, and when

Fundz watches for the moments Enveric Biosciences starts buying, and tells you who to reach.

  • An alert the day Enveric Biosciences raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Enveric Biosciences, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Enveric Biosciences. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Enveric Biosciences and Aries Science & Technology Announce Licensing Agreement for Clinical Development of Radiation Dermatitis Topical Product

Jul 15, 2024

Contract Type

agreement

CambridgeBiotechnologyHealthcareHealth CareScience And Engineering

Description

Enveric Biosciences and Aries Science & Technology have announced a licensing agreement for the clinical development of Enveric’s patented radiation dermatitis topical product. The formulation licensed to Aries is estimated to have a market opportunity of $400 million annually.

Company Information

Company

Enveric Biosciences

Location

Cambridge, Massachusetts, United States

About

Enveric Biosciences (NASDAQ: ENVB) is an innovative biotechnology company developing a next-generation mental health and oncology treatment clinical discovery platform, leveraging psychedelic-derived molecules for the mind and synthetic cannabinoids for the body. Enveric's robust pipeline supports drug development from the clinic to commercialization for millions of patients in need around the world suffering from conditions that include cancer-related distress, PTSD and more.

Related People

Kevin
Likely contact at this company
••••••••@••••••••

See Kevin's verified email →

Sheetal
Senior decision-maker at this company
••••••••@••••••••

See Sheetal's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Enveric Biosciences's next move

Learn about Strategic plan

Enveric Biosciences signed a new agreement. Fundz surfaces partnerships and contracts as they are announced.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.